Airway (AWM) - Total Assets
Based on the latest financial reports, Airway (AWM) holds total assets worth zł12.28 Million PLN (≈ $3.38 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check total reinvestment intensity of Airway to assess the company's total reinvestment commitment from operating cash flow.
Airway - Total Assets Trend (2014–2025)
This chart illustrates how Airway's total assets have evolved over time, based on quarterly financial data. Explore Airway strategic investment ratio to see how much of total assets are deployed in long-term investments.
Airway - Asset Composition Analysis
Current Asset Composition (December 2025)
Airway's total assets of zł12.28 Million consist of 9.7% current assets and 90.3% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 1.0% |
| Accounts Receivable | zł122.00K | 1.0% |
| Inventory | zł73.00K | 0.6% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł9.99 Million | 81.3% |
| Goodwill | zł0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Airway's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Airway.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Airway's current assets represent 9.7% of total assets in 2025, an increase from 2.6% in 2014.
- Cash Position: Cash and equivalents constituted 1.0% of total assets in 2025, up from 0.9% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 81.0% of total assets, an increase from 61.0% in 2014.
- Asset Diversification: The largest asset category is intangible assets at 81.3% of total assets.
Airway Competitors by Total Assets
Key competitors of Airway based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Tarsons Products Limited
NSE:TARSONS
|
India | Rs11.64 Billion |
|
SciVision Biotech Inc
TW:1786
|
Taiwan | NT$2.67 Billion |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
Airway - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.07 | 0.18 | 1.46 |
| Quick Ratio | 0.07 | 0.18 | 1.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł-15.68 Million | zł-14.85 Million | zł8.03 Million |
Airway - Advanced Valuation Insights
This section examines the relationship between Airway's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.99 |
| Latest Market Cap to Assets Ratio | 0.65 |
| Asset Growth Rate (YoY) | 221.9% |
| Total Assets | zł12.28 Million |
| Market Capitalization | $7.98 Million USD |
Valuation Analysis
Below Book Valuation: The market values Airway's assets below their book value (0.65x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Airway's assets grew by 221.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Airway (2014–2025)
The table below shows the annual total assets of Airway from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | zł12.28 Million ≈ $3.38 Million |
+221.88% |
| 2024-12-31 | zł3.82 Million ≈ $1.05 Million |
-48.16% |
| 2023-12-31 | zł7.36 Million ≈ $2.03 Million |
+18.48% |
| 2022-12-31 | zł6.21 Million ≈ $1.71 Million |
-86.04% |
| 2021-12-31 | zł44.50 Million ≈ $12.25 Million |
-13.57% |
| 2020-12-31 | zł51.48 Million ≈ $14.17 Million |
+17.63% |
| 2019-12-31 | zł43.77 Million ≈ $12.05 Million |
-4.13% |
| 2018-12-31 | zł45.65 Million ≈ $12.56 Million |
+60.20% |
| 2017-12-31 | zł28.50 Million ≈ $7.84 Million |
-1.65% |
| 2016-12-31 | zł28.98 Million ≈ $7.97 Million |
+26.90% |
| 2015-12-31 | zł22.83 Million ≈ $6.28 Million |
-49.32% |
| 2014-12-31 | zł45.05 Million ≈ $12.40 Million |
-- |
About Airway
Airway Medix S.A. engages in the research, development, and commercialization of medical devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments in Poland and internationally. It offers Closed Suction System, a dual operation of balloon swiping and suction; B-Oral Care for intubated hospita… Read more